Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

Jemincare Announces Exclusive License Agreement with Genentech to Develop and Commercialize Novel Oral Androgen Receptor Degrader

SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- Jemincare, a leading pharmaceutical company fromChina, announced today that it and its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., have entered into an exclusive worldwide license agreement with Roche (SIX: RO, ROG; OTCQX: ...

2022-08-18 15:25 2294

Innovent Announces First Subject Dosed in Phase 1 Study of IBI311 (Anti-IGF-1R Monoclonal Antibody)

SAN FRANCISCO and SUZHOU, China, Aug. 18, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...

2022-08-18 08:00 2689

TurtleTree Announces LF+, the First-Ever Sustainable Lactoferrin Made With Precision Fermentation

WOODLAND, Calif. and SINGAPORE, Aug. 17, 2022 /PRNewswire/ -- Following 18 months of extensive R&D, TurtleTree has officially announced its production of LF+, the world's ﬁrst sustainable bovine lactoferrin created using precision fermentation technology.

2022-08-17 22:00 4174

TurtleTree Announces LF+, the First-Ever Sustainable Lactoferrin Made With Precision Fermentation

AMETEK Thailand Opens New Office and Centre of Excellence to Provide Customers in Southeast Asia with AMETEK's latest Technology Solutions

BANGKOK, Aug. 17, 2022 /PRNewswire/ -- AMETEK Thailand is pleased to announce that it has opened a new, state-of-the-art facility in a convenient location in Bangkok that will provide enhanced support for customers throughout the Southeast Asia region. AMETEK Thailand began operations in 2017 and...

2022-08-17 15:07 2525

JOYSBIO HAS DEVELOPED NEW MONKEYPOX RAPID TESTS

JOYSBIO, one of the world's leading manufacturers of rapid test kits, has developed two new Monkeypox tests that deliver results in 15 minutes TIANJIN, China, Aug. 17, 2022 /PRNewswire/ -- JOYSBIO, one of the world's leading manufacturers of lateral flow rapid test kits, is proud to announce the...

2022-08-17 14:30 2457

Increased Precision and Safety in Spinal Tap with PASS - An Ultrasound-Guided Lumbar Puncture Procedure

BANGKOK, Aug. 17, 2022 /PRNewswire/ -- PASS (Point-Assisted Spinal Sonography), an ultrasound-guided lumbar puncture device from Chula doctors and engineers, helps increase the precision and confidence in spinal tap procedures while reducing risks and pain for patients.

2022-08-17 10:00 2348

Increased Precision and Safety in Spinal Tap with PASS - An Ultrasound-Guided Lumbar Puncture Procedure

Milieu Insight latest study explores the relationship between social media usage and mental health

SINGAPORE, Aug. 17, 2022 /PRNewswire/ -- Milieu Insight , the award-winning consumer research and analytics company, today shared the results of its latest study that explores the relationship between social media usage and mental well-being. To unpack the findings, the fi...

2022-08-17 09:07 3341

Global Cord Blood Corporation Files Annual Report on Form 20-F

HONG KONG, Aug. 17, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual ...

2022-08-17 04:16 2693

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML

Companion diagnostic would be used following potential regulatory approval of entospletinib to screen for NPM1 mutation present in approximately one-third of all patients with AML Entospletinib is currently being studied in the Phase 3 AGILITY registrational study, with data anticipated in seco...

2022-08-17 04:05 2534

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML

Vision Loss Rehabilitation Canada brings AI-driven diabetic eye screening to rural and Indigenous communities

Program selects Eyenuk's EyeArt AI system to make vision-saving screening more accessible in remoteOntario communities LOS ANGELES and TORONTO, Aug. 16, 2022 /PRNewswire/ -- Vision Loss Rehabilitation Canada (VLRC), Canada's leading provider of rehabilitation therapy and healthcare services for ...

2022-08-16 20:00 2279

Medison Pharma Announces the Expansion of its Partnership with Albireo to a Multi-Regional Agreement to Commercialize Odevixibat in Canada and Israel

PETACH TIKVAH, Israel, Aug. 16, 2022 /PRNewswire/ -- Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced today the expansion of its partnership withAlbireo ...

2022-08-16 19:30 2323

Manulife Hong Kong and Hong Kong Association of Athletics Affiliates form partnership to establish the Manulife GBA HK-Zhuhai-Macao Bridge Half-Marathon

HONG KONG, Aug. 16, 2022 /PRNewswire/ -- Manulife Hong Kong and the Hong Kong Association of Athletics Affiliates (HKAAA) today jointly announced the signing of a Memorandum of Understanding for a partnership that will bring the first-ever Manulife GBA HK-Zhuhai-Macao Bridge (HZMB) Half-Marath...

2022-08-16 16:12 2795

Manulife Hong Kong and Hong Kong Association of Athletics Affiliates form partnership to establish the Manulife GBA HK-Zhuhai-Macao Bridge Half-Marathon

ExoCoBio's First Global Regenerative Aesthetic Exosome Summit

* World First Regenerative Aesthetic Exosome Summit (RAES 2022) * Participation of Global Exosome and Regenerative Aesthetic Authorities * Plan to Grow into a Global Platform for Exosome and Regenerative Aesthetic Industry in the Future SEOUL, South Korea, Aug. 16, 2022 /PRNewswire/ -- ExoCo...

2022-08-16 15:00 5683

ExoCoBio's First Global Regenerative Aesthetic Exosome Summit

Sirnaomics Develops Peptide Docking Vehicle (PDoV(TM)) Designed for an Enhanced GalNAc Delivery Platform for Novel siRNA Therapeutics

A proprietary GalNAc delivery system with enhanced Endosome Escape and Dual-Targeting GAITHERSBURG, Md. and SUZHOU, China, Aug. 16, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi ...

2022-08-16 14:48 2702

ICP DAS - BMP will attend MEDICAL MANUFACTURING ASIA 2022 in Singapore

TAIPEI, Aug. 16, 2022 /PRNewswire/ -- ICP DAS - BMP (Biomedical Polymers), a Taiwanese medical TPU (thermoplastic polyurethane) supplier, will exhibit at MEDICAL MANUFACTURINGASIA 2022, the 5th Manufacturing Processes for Medical Technology Exhibition and Conference, which provides excellent busi...

2022-08-16 10:15 2609

ICP DAS - BMP will attend MEDICAL MANUFACTURING ASIA 2022 in Singapore

Intellect Partners With Banyan Tree Bintan to roll out an exclusive luxury resort wellbeing experience

* Intellect joins hands with Banyan Tree Bintan resort for the latest holistic wellbeing program in the industry: Banyan Tree Wellbeing Sanctuary * This partnership brings Intellect's comprehensive mental wellbeing platform into the hospitality industry through Banyan Tree's extensive guest an...

2022-08-16 10:00 2513

Antengene Announces First Patient Dosed of Small Molecule ATR ATG-018 for the Treatment of Patients with Advanced Solid Tumors and Hematologic Malignancies in Australia

* ATG-018, a global rights asset developed by Antengene's internal R&D team, is anorally-bioavailable, small molecule ataxia telangiectasia and Rad3-associated (ATR) kinase inhibitorthat targets the DNA damage response (DDR) pathways. * The Phase I study will evaluate the safety, pharmacology...

2022-08-16 08:30 2720

Gannex Announces First Subject Dosed in the U.S. Drug-Drug Interaction Study of FXR Agonist ASC42 for Treatment of Primary Biliary Cholangitis

-- Enrollment of the total 12 subjects is expected to be completed in August 2022 -- The DDI study on ASC42 in the U.S. is expected to be completed by the beginning of the fourth quarter 2022 -- This DDI study and ongoing Phase II clinical trial in PBC patients in China will provide more eviden...

2022-08-16 08:10 2284

Everest Medicines Enters into Agreement with Gilead Sciences for Trodelvy in Asia Territories

Everest to receive total considerations of up to $455 million with $280 million in upfront payments Broadens development and access to Trodelvy for patients in Greater China and certain Asia Pacific Markets Strengthens balance sheet and streamlines resources to advance robust pipeline of first-...

2022-08-16 07:15 2695

ROKIT Healthcare to Enable Innovation in Treatment of Diabetes Foot and Osteoarthritis Combining AI and 3D Bioprinting on Google Cloud

SEOUL, South Korea, Aug. 15, 2022 /PRNewswire/ -- ROKIT Healthcare, a company specializing in bio-healthcare, today announced it will provide a hyper-personalized medical platform that uses 3D bioprinting and AI technology built on Google Cloud, to innovate the treatment of osteoarthritis and dia...

2022-08-15 07:00 4578

ROKIT Healthcare to Enable Innovation in Treatment of Diabetes Foot and Osteoarthritis Combining AI and 3D Bioprinting on Google Cloud

1 ... 173 174 175176177 178 179 ... 553